Cannara Biotech Inc. to Webcast Live at VirtualInvestorConferences.com on January 20, 2022
Cannara Biotech Inc. (TSXV: LOVE, OTCQB: LOVFF) will host a live presentation on January 20, 2022, at 2:30 PM Eastern via VirtualInvestorConferences.com. The company's CFO, Nicholas Sosiak, invites individual and institutional investors to engage with Cannara in real-time. The event will also be archived for later access. Recent highlights include an upsized CIBC credit facility of $22 million, a cultivation license for the Valleyfield Facility, and recorded fiscal 2021 revenues of $17.3 million.
- None.
- None.
Company invites individual and institutional investors, as well as advisors and analysts, to attend a real-time, interactive presentation on VirtualInvestorConferences.com
MONTREAL, Jan. 18, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that Nicholas Sosiak, Chief Financial Officer will present live at VirtualInvestorConferences.com on January 20th, 2022.
DATE: January 20th, 2022
TIME: 2:30pm Eastern
LINK: https://bit.ly/3JUNHjN
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
- Cannara Biotech Inc. upsizes CIBC Credit Facility to
$22 million ; - Cannara's Valleyfield Facility Receives Processing and Cultivation License;
- Company Recorded Fiscal 2021 Revenues of
$17.3 Million ; - Company had Second Consecutive Quarter of Positive Adjusted EBITDA of
$1.4 million in the Fourth Quarter of Fiscal 2021.
About Cannara Biotech Inc.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Québec and Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 125,000kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara's facilities produce craft-cultivated premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cannara-biotech-inc-to-webcast-live-at-virtualinvestorconferencescom-on-january-20-2022-301462375.html
SOURCE Cannara Biotech Inc.
FAQ
When is Cannara Biotech's presentation on Virtual Investor Conferences?
How can I attend Cannara Biotech's live presentation?
What are the recent financial highlights for Cannara Biotech?
Who is presenting for Cannara Biotech during the virtual event?
Is there an archive of the Cannara Biotech presentation available?
